Literature DB >> 31322546

Spinal versus intracranial meningioma: Expression of E-cadherin and Fascin with relation to clinicopathological features.

Abd AlRahman Mohammad Foda1,2, Mariya Syed Alam2, Nadeem Ikram2, Samia Rafi2, Khaled Elnaghi3,4.   

Abstract

BACKGROUND: E-cadherin and Fascin are adhesive proteins that are expressed in many tumors. It was supposed that loss of expression of these proteins is associated with increased aggressiveness of the tumor. Whether spinal and intracranial meningiomas express adhesion proteins in different rates is not yet known.
OBJECTIVE: We aimed to investigate the expression of E-cadherin and Fascin in a large number of meningioma specimens and determine if clinical and prognostic significance exists
METHODS: One hundred and thirty-four spinal and intracranial meningioma samples were collected. Manual TMA blocks were constructed and immunohistochemistry for E-cadherin and Fascin was done. Focal or diffuse staining was considered positive.
RESULTS: Intracranial meningioma occurred in significantly younger age than spinal ones. Most of spinal meningiomas were of transitional histology. E-cadherin was expressed in 38.8% of cases. Spinal meningiomas showed statistically significant negative expression of E-cadherin than intracranial tumors. All atypical meningiomas showed negative E-cadherin expression. Fascin was expressed in 9% of cases with significant expression in atypical cases.
CONCLUSIONS: Aggressive behavior of meningioma could be explained in part by loss of E-cadherin and overexpression of Fascin especially in spinal meningiomas. Further studies are suggested to explore the biological aspects of spinal and intracranial meningiomas for constructing tailored targeted therapies.

Entities:  

Keywords:  E-cadherin; Fascin; intracranial meningioma; spinal meningioma

Year:  2019        PMID: 31322546     DOI: 10.3233/CBM-190164

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  3 in total

Review 1.  Molecular Mechanism and Approach in Progression of Meningioma.

Authors:  Zhiwei Shao; Lihong Liu; Yanghao Zheng; Sheng Tu; Yuanbo Pan; Sheng Yan; Qichun Wei; Anwen Shao; Jianmin Zhang
Journal:  Front Oncol       Date:  2020-09-11       Impact factor: 6.244

2.  Fascin-1 and its role as a serological marker in prostate cancer: a prospective case-control study.

Authors:  Octavian Sabin Tătaru; Orsolya Martha; Felice Crocetto; Biagio Barone; Septimiu Voidazan; Angela Borda; Anca Sin; Adina Hutanu; Andrada Loghin; Ileana Sin; Daniel Porav-Hodade; Calin Bogdan Chibelean; Liliana Vartolomei; Giuseppe Lucarelli; Matteo Ferro; Virgil Gheorghe Osan; Carlo Buonerba; Mihai Dorin Vartolomei
Journal:  Future Sci OA       Date:  2021-06-30

3.  Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial-mesenchymal transition.

Authors:  Hong You; Jian Xu; Xiaochun Qin; Guodong Qian; Yang Wang; Fulei Chen; Xiaoxu Shen; Dong Zhao; Qi Liu
Journal:  J Mol Histol       Date:  2021-06-07       Impact factor: 2.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.